IP Library Granted Patent US 6,960,341
Granted Patent B2
US 6,960,341 · App. 10/621,296 · Granted Nov 1, 2005

Bifidobacteria and preparations containing them

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,960,341
App. No.
10/621,296
Granted
Nov 1, 2005
Kind
B2
Abstract

The disclosure refers to biologically pure cultures of two strains of Bifidobacterium Longum named W11 and W11 a and deposited at the Belgian Coordinated Collections of Microorganisms (BCCM) that has registered them under the accession numbers LMG P-21586 and LMG P-21587. They are used as probiotics within preparations of pharmaceutical or alimentary products to help the gastrointestinal health and to prevent and treat the intestinal pathologies.

Claims (14)

1. A biologically pure culture of a strain Bifidobacterium Longum LMG P-21586.

2. A biologically pure culture of a strain Bifidobacterium Longum LMG P-21587.

3. A pharmaceutical or alimentary preparation containing between 1×10 7 and 1×10 11 colony forming units of live cells of a biologically pure culture of a strain Bifidobacterium Longum LMG P-21586.

4. Preparation according to claim 3 , comprising oligosaccharides.

5. Preparation according to claim 4 , wherein the oligosaccharides are fructo-oligosaccharides with a polymerization degree between 2 and 10.

6. Preparation according to claim 3 , comprising vitamins.

7. Preparation according to claim 6 , wherein the vitamins are selecting from the group consisting of vitamins E, B1, B2, B6 and B12.

8. Preparation according to claim 3 , in a form selected from the group consisting of capsules, tablets, packets, troches, liquid suspensions, dry oral supplements, liquid oral supplements, vials, milk, yogurt, fresh cheese, ice-creams, products made of fermented cereals, milk powders, children's products and products for domestic animals.

9. A pharmaceutical or alimentary preparation containing between 1×10 7 and 1×10 11 colony forming units of live cells of a biologically pure culture of a strain Bifidobacterium Longum LMG P-21587.

10. Preparation according to claim 9 , comprising oligosaccharides.

11. Preparation according to claim 10 , wherein the oligosacharides are fructo-oligosaccharides with a polymerization degree between 2 and 10.

12. Preparation according to claim 9 , comprising vitamins.

13. Preparation according to claim 12 , wherein the vitamins are selected from the group vitamins E, B1, B2, B6 and B12.

14. Preparation according to claim 9 , in a form selected from the group consisting of capsules, tablets, packets, troches, liquid suspensions, dry oral supplements, liquid oral supplements, vials, milk, yogurt, fresh cheese, ice-creams, products made of fermented cereals, milk powders, children's products and products for domestic animals.

Assignments (3)
CHANGE OF ADDRESS Recorded Oct 15, 2019
From: ALFASIGMA S.P.A.
To: ALFASIGMA S.P.A.
Reel/Frame 050727/0652 →
MERGER Recorded Nov 14, 2017
From: ALFA WASSERMANN S.P.A.
To: ALFASIGMA S.P.A.
Reel/Frame 045061/0645 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2003
From: VISCOMI, CLAUDIO GIUSEPPE; ROTINI, LEONE GABRIELE; MORELLI, LORENZO; FERRARI, PATRIZIO; PANTALEO, MARIA ROSARIA
To: ALFA WASSERMAN S.P.A.
Reel/Frame 014304/0780 →